Regencell Bioscience Holdings Limited (RGC) NASDAQ
23.41
-0.762(-3.15%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
23.41
-0.762(-3.15%)
Currency In USD
Address
First Commercial Building
Causeway Bay, KY1-1107
Hong Kong
Phone
852 2155 0823
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
12
First IPO Date
July 16, 2021
| Name | Title | Pay | Year Born |
| Yat-Gai Au | Founder, Chairman & Chief Executive Officer | 0 | 1973 |
| Wai Hong Chung | Chief Operating Officer, Chief Strategy Officer & Director | 245,642 | 1978 |
| Antonia Assang | Senior Vice President of Project Management | 0 | N/A |
| Michelle Chan | Financial Controller, Chief Financial Officer & Principal Financial Officer | 0 | N/A |
| Yat-Pui Au | Chief Business Officer | 0 | 1975 |
Regencell Bioscience Holdings Limited operates a Traditional Chinese medicine (TCM) bioscience company. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.